Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moroni

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 1, 1988
[Chitosan. Biochemical structural characteristics and bio-morphology]A Pugnaloni, R Solmi, R Muzzarelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Characterization of 2,4,5-trihydroxyphenylalanine neurotoxicity in vitro and protective effects of ganglioside GM1: implications for Parkinson's diseaseS D Skaper, L Facci, N Schiavo, et al.
European Journal of Pharmacology|June 25, 1991
Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptorF Moroni, M Alesiani, A Galli, et al.
The New England Journal of Medicine|March 17, 1983
Naloxone administration releases catecholaminesM Mannelli, M Maggi, M L De Feo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acidF Moroni, A Galli, G Mannaioni, et al.
Neuroscience|July 1, 1994
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activitiesR Carpenedo, A Chiarugi, P Russi, et al.
Neuroscience|July 26, 2011
In vivo detection of cortical abnormalities in BCNU-treated rats, model of cortical dysplasia, using manganese-enhanced magnetic resonance imagingR F Moroni, I Zucca, F Inverardi, et al.
Pharmacological Research Communications|November 1, 1987
Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophanL Bacciottini, D E Pellegrini-Giampietro, F Bongianni, et al.
Journal of Neurochemistry|August 2, 2007
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivoG Faraco, S Fossati, M E Bianchi, et al.
Neuropharmacology|October 26, 1999
Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanismsD E Pellegrini-Giampietro, F Peruginelli, E Meli, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 1, 1988
[Chitosan. Biochemical structural characteristics and bio-morphology]A Pugnaloni, R Solmi, R Muzzarelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Characterization of 2,4,5-trihydroxyphenylalanine neurotoxicity in vitro and protective effects of ganglioside GM1: implications for Parkinson's diseaseS D Skaper, L Facci, N Schiavo, et al.
European Journal of Pharmacology|June 25, 1991
Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptorF Moroni, M Alesiani, A Galli, et al.
The New England Journal of Medicine|March 17, 1983
Naloxone administration releases catecholaminesM Mannelli, M Maggi, M L De Feo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acidF Moroni, A Galli, G Mannaioni, et al.
Neuroscience|July 1, 1994
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activitiesR Carpenedo, A Chiarugi, P Russi, et al.
Neuroscience|July 26, 2011
In vivo detection of cortical abnormalities in BCNU-treated rats, model of cortical dysplasia, using manganese-enhanced magnetic resonance imagingR F Moroni, I Zucca, F Inverardi, et al.
Pharmacological Research Communications|November 1, 1987
Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophanL Bacciottini, D E Pellegrini-Giampietro, F Bongianni, et al.
Journal of Neurochemistry|August 2, 2007
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivoG Faraco, S Fossati, M E Bianchi, et al.
Neuropharmacology|October 26, 1999
Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanismsD E Pellegrini-Giampietro, F Peruginelli, E Meli, et al.
Pageof 25